Newly identified DNA repair defect linked to increased risk of leukemia relapse

A newly identified defect in a DNA repair system might leave some young leukemia patients less likely to benefit from a key chemotherapy drug, possibly putting them at greater risk of relapse. The problem was identified in a study led by St. Jude Children's Research Hospital scientists.

Read the whole article on Physorg

More from Physorg